The estimated Net Worth of David E Shaw is at least 78.4 百万$ dollars as of 28 September 2020. David Shaw owns over 488,206 units of Schrodinger stock worth over 1,750,103$ and over the last 4 years David sold SDGR stock worth over 76,609,986$.
David has made over 3 trades of the Schrodinger stock since 2020, according to the Form 4 filled with the SEC. Most recently David sold 488,206 units of SDGR stock worth 23,536,411$ on 28 September 2020.
The largest trade David's ever made was selling 573,889 units of Schrodinger stock on 15 September 2020 worth over 30,450,550$. On average, David trades about 505,336 units every 4 days since 2020. As of 28 September 2020 David still owns at least 85,039 units of Schrodinger stock.
You can see the complete history of David Shaw stock trades at the bottom of the page.
David's mailing address filed with the SEC is 120 WEST 45TH STREET, 39TH FLOOR, , NEW YORK, NY, 10036.
Over the last 5 years, insiders at Schrodinger have traded over 1,009,056,149$ worth of Schrodinger stock and bought 838,235 units worth 14,249,995$ . The most active insiders traders include & Melinda Gates Foundation ...、David E Schrodinger Equity ...、Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of 2,459,207$. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth 24,191$.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrodinger executives and other stock owners filed with the SEC include: